Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma
Clinical trial NCT00992173 · WITHDRAWN
Trial details
- NCT number
- NCT00992173
- Sponsor
- Molecular Insight Pharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2011-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.